MedTrace Logo

Role of Anabolic Steroids on Intensive Care Unit-Acquired Weakness

NCT03038919 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2017-02-01

No results posted yet for this study

Summary

The researchers intend to investigate possible anabolic effects of bi-weekly exogenous testosterone administration during intensive care unit (ICU) stay for up to 8 weeks. Control group will receive standard ICU management and will also be followed during ICU stay.

Conditions

  • Critical Illness Polyneuropathies

Interventions

DRUG

Testosterone cypionate

Bi-weekly intramuscular injection of testosterone cypionate 200mg.

OTHER

Standard nutrition and physical therapy at ICU

follow-up of the patient without use of testosterone cypionate

Sponsors & Collaborators

  • Hospital de Clinicas de Porto Alegre

    lead OTHER

Principal Investigators

  • Silvia RR Vieira, PhD · Hospital de Clínicas de Porto Alegre - RS

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2017-10-31
Completion
2018-01-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03038919 on ClinicalTrials.gov